NCT07330648: Prospective Clinical Trial of Crisugabalin Capsules in the Treatment of Generalized Anxiety Disorder
- State
- Under way
- Phase
- Phase 2
- People
- 216 planned
- Started
- 10 Oct 2025
- Primary completion
- 31 Jan 2027
- Arms
- Crisugabalin 80mg/day group
- Results
- None posted
- 10 Oct 2025: Trial started
- 9 Jan 2026: Trial registered